UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNT
2351
Brookfield Wealth Solutions
BNT
$12.2B
| $1.16M | ﹤0.01% |
28,134
+4,954
| +21% | +$183K |
|
2352
South Plains Financial
SPFI
$841M
| $1.16M | ﹤0.01% |
32,082
+12,106
| +61% | +$416K |
|
2353
Target Hospitality
TH
$1.64B
| $1.15M | ﹤0.01% |
160,938
+43,622
| +37% | +$303K |
|
|
DAWN
2354
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.14M | ﹤0.01% |
175,416
+63,137
| +56% | +$434K |
|
2355
Atlas Energy Solutions
AESI
$1.41B
| $1.14M | ﹤0.01% |
85,159
+39,336
| +86% | +$537K |
|
2356
Willis Lease Finance
WLFC
$1.29B
| $1.13M | ﹤0.01% |
23,820
+7,503
| +46% | +$354K |
|
2357
Iovance Biotherapeutics
IOVA
$2.87B
| $1.13M | ﹤0.01% |
657,209
-5,120,135
| -89% | -$12.7M |
|
|
CSR
2358
Centerspace
CSR
$952M
| $1.13M | ﹤0.01% |
18,753
-4,832
| -20% | -$296K |
|
2359
Enanta Pharmaceuticals
ENTA
$400M
| $1.13M | ﹤0.01% |
149,178
-10,319
| -6% | -$62.1K |
|
2360
Forestar Group
FOR
$1.51B
| $1.13M | ﹤0.01% |
56,347
+5,332
| +10% | +$105K |
|
2361
GoodRx Holdings
GDRX
$1.26B
| $1.13M | ﹤0.01% |
226,272
+86,023
| +61% | +$374K |
|
2362
Cricut
CRCT
$1.22B
| $1.12M | ﹤0.01% |
165,255
+41,511
| +34% | +$237K |
|
2363
LendingTree
TREE
$451M
| $1.11M | ﹤0.01% |
29,970
+10,819
| +56% | +$437K |
|
2364
Li Auto
LI
$12.7B
| $1.11M | ﹤0.01% |
40,968
+20,484
| +100% | +$541K |
|
2365
AnaptysBio
ANAB
$1.68B
| $1.11M | ﹤0.01% |
49,805
+14,892
| +43% | +$312K |
|
|
RPC
2366
Ridgepost Capital
RPC
$991M
| $1.1M | ﹤0.01% |
107,711
+32,060
| +42% | +$343K |
|
2367
Kura Oncology
KURA
$850M
| $1.09M | ﹤0.01% |
189,720
+37,588
| +25% | +$230K |
|
|
CVAC
2368
DELISTED
CureVac
CVAC
| $1.09M | ﹤0.01% |
201,329
-78,327
| -28% | -$311K |
|
2369
Hovnanian Enterprises
HOV
$807M
| $1.09M | ﹤0.01% |
10,380
+5,001
| +93% | +$490K |
|
2370
Aspen Aerogels
ASPN
$518M
| $1.09M | ﹤0.01% |
183,309
+44,887
| +32% | +$258K |
|
2371
Central Garden & Pet Co
CENT
$2.8B
| $1.08M | ﹤0.01% |
30,739
-956
| -3% | -$33.8K |
|
|
TIGR
2372
UP Fintech Holding
TIGR
$861M
| $1.06M | ﹤0.01% |
110,200
-19,900
| -15% | -$166K |
|
2373
Heartland Express
HTLD
$956M
| $1.06M | ﹤0.01% |
122,888
+13,726
| +13% | +$118K |
|
|
MFA
2374
MFA Financial
MFA
$933M
| $1.06M | ﹤0.01% |
111,785
+16,211
| +17% | +$153K |
|
2375
Esquire Financial Holdings
ESQ
$1.14B
| $1.04M | ﹤0.01% |
10,963
+7,298
| +199% | +$630K |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.